These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15746385)

  • 1. Adherence to hepatitis B virus vaccination at syringe exchange sites.
    Altice FL; Bruce RD; Walton MR; Buitrago MI
    J Urban Health; 2005 Mar; 82(1):151-61. PubMed ID: 15746385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of a hepatitis B vaccination program for clients of a drug consumption facility.
    Scherbaum N; Timm J; Richter F; Bonnet U; Bombeck J; Lajos S; Specka M
    J Clin Virol; 2018 Sep; 106():28-32. PubMed ID: 30015286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
    Alanko Blomé M; Björkman P; Flamholc L; Jacobsson H; Widell A
    Vaccine; 2017 Jan; 35(1):84-90. PubMed ID: 27894721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of delivering hepatitis B vaccine to injection drug users.
    Hu Y; Grau LE; Scott G; Seal KH; Marshall PA; Singer M; Heimer R
    Am J Prev Med; 2008 Jul; 35(1):25-32. PubMed ID: 18541174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection.
    Kuo I; Sherman SG; Thomas DL; Strathdee SA
    Drug Alcohol Depend; 2004 Jan; 73(1):69-78. PubMed ID: 14687961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities.
    Bowman S; Grau LE; Singer M; Scott G; Heimer R
    BMC Public Health; 2014 Aug; 14():820. PubMed ID: 25107530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
    Mast EE; Weinbaum CM; Fiore AE; Alter MJ; Bell BP; Finelli L; Rodewald LE; Douglas JM; Janssen RS; Ward JW;
    MMWR Recomm Rep; 2006 Dec; 55(RR-16):1-33; quiz CE1-4. PubMed ID: 17159833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge of hepatitis among active drug injectors at a syringe exchange program.
    Carey J; Perlman DC; Friedmann P; Kaplan WM; Nugent A; Deutscher M; Masson CL; Des Jarlais DC
    J Subst Abuse Treat; 2005 Jul; 29(1):47-53. PubMed ID: 15979531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.
    Bialek SR; Bower WA; Mottram K; Purchase D; Nakano T; Nainan O; Williams IT; Bell BP
    J Urban Health; 2005 Sep; 82(3):468-78. PubMed ID: 16049202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccination for injection drug users--Pierce County, Washington, 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 May; 50(19):388-90, 399. PubMed ID: 11465908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus serum profiles in injection drug users and rates of immunization over time in Barcelona: 1987-2006.
    Rivas I; Martinez E; Sanvisens A; Bolao F; Tor J; Torrens M; Pujol R; Fuster D; Rey-Joly C; Muñoz A; Muga R
    Drug Alcohol Depend; 2010 Aug; 110(3):234-9. PubMed ID: 20456873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptance and completion of hepatitis B vaccination among drug users in New York City.
    Ompad DC; Galea S; Wu Y; Fuller CM; Latka M; Koblin B; Vlahov D
    Commun Dis Public Health; 2004 Dec; 7(4):294-300. PubMed ID: 15779793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
    Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV
    J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status.
    Day CA; White B; Dore GJ; van Beek I; Rodgers C; Cunningham P; Wodak A; Maher L
    Drug Alcohol Depend; 2010 Apr; 108(1-2):134-7. PubMed ID: 20047803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users.
    Campbell JV; Garfein RS; Thiede H; Hagan H; Ouellet LJ; Golub ET; Hudson SM; Ompad DC; Weinbaum C;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S64-72. PubMed ID: 17276018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study.
    Lum PJ; Ochoa KC; Hahn JA; Page Shafer K; Evans JL; Moss AR;
    Am J Public Health; 2003 Jun; 93(6):919-23. PubMed ID: 12773355
    [No Abstract]   [Full Text] [Related]  

  • 20. Gender differences in hepatitis C seroprevalence and suboptimal vaccination and hepatology services uptake amongst substance misusers.
    Marufu M; Williams H; Hill SL; Tibble J; Verma S
    J Med Virol; 2012 Nov; 84(11):1737-43. PubMed ID: 22997076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.